Two years after its launch, US FDA's device center will convene the first meeting of its Patient Engagement Advisory Committee in October to discuss patient perspectives in clinical trials.
On July 25, CDRH Director Jeff Shuren and Kathryn O’Callaghan, assistant director for strategic programs at the center announced the first meeting of the Patient Engagement Advisory Committee, or PEAC, in an agency blog post. According to the FDA officials the group of nine committee members will meet for the first time on Oct. 11-12 in Gaithersburg, Md. to discuss challenges of clinical trial design, conduct, and reporting identified by patients
PEAC Roster
- Paul T. Conway (Chair), president of the American Association of Kidney Patients
- Katherine Seelman (Consumer Representative), Retired professor of rehabilitation science and technology, University of Pittsburgh
- Cynthia L. Chauhan, patient advocate and retired social worker
- Bennet R. Dunlap, consultant and diabetes advocate
- Frederick Downs, Jr., retired Veterans Administration procurement and logistics officer; decorated Vietnam veteran
- Amye Leong, president and CEO of Health Motivations
- Monica Willis-Parker, director of the Minority Engagement Core, Emory Alzheimer’s Disease Research Center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
